BIIB reports Q2 EPS $2.30, consensus $1.93 Reports Q2 revenue $1.7B, consensus $1.62B. AVONEX revenues increased 2% year-over-year to $774M. TYSABRI revenues increased 38% year-over-year to $387M. raises 2013 EPS outlook to $8.25-$8.50, consensus $8.22 Revenue growth is expected to be approximately 22%-23%.